Curaleaf Hldgs Stock Price, News & Analysis

Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) will announce its fourth quarter and fiscal year 2022 financial results on March 28, 2023, before market open. The company plans to conduct a conference call at 8:30 a.m. ET for discussing operational and financial highlights, followed by a Q&A session. Curaleaf operates 147 dispensaries across 19 states in the U.S. and is a leader in the cannabis industry, focusing on consumer product clarity and confidence.

Curaleaf Holdings, operating in Connecticut, has initiated adult-use cannabis sales at its Hartford dispensary starting March 1, 2023. This marks the first adult-use dispensary in Hartford and follows similar sales launched in Stamford earlier this year. Curaleaf aims to enhance consumer experience by providing diverse product offerings and a revamped loyalty rewards program. Existing medical patients will benefit from priority access and dedicated services. The company plans to expand its adult-use services further, pending regulatory approvals, reinforcing its commitment to serving both medical and adult-use markets in Connecticut.

Curaleaf Holdings, Inc. (CSE: CURA; OTCQX: CURLF) announces the opening of its first dispensary in Stamford, Connecticut, which will begin adult-use cannabis sales on January 28, 2023, at 10:00 a.m. This new location expands Curaleaf's footprint in Connecticut, where it already serves medical patients at three other dispensaries. To celebrate the launch, the Stamford dispensary will host festivities including product discounts and giveaways. The company aims to maintain quality care for its medical patients while welcoming adult-use consumers. Curaleaf operates in 19 states, with 147 dispensaries and nearly 5,500 employees, positioning itself strongly in the cannabis market.

Curaleaf Holdings (CURLF) is streamlining operations by closing most facilities in California, Colorado, and Oregon, aiming to enhance cash flow and profitability. The company anticipates a 10% workforce reduction, targeting gross run-rate savings of $60 million, surpassing initial goals. Despite these states contributing less than $50 million in revenue last year, Curaleaf believes these measures will boost adjusted EBITDA margins and free cash flow, projected to exceed $125 million in 2023. CEO Matt Darin emphasizes the need for improved margins and cash generation in core markets, stating these strategic moves are essential for the company's future success.

Curaleaf has expanded its Grassroots brand into New Jersey, introducing premium cannabis flower and pre-rolls in the state. This marks New Jersey as the eighth market for Grassroots products following the brand's national rebranding in November 2022. Five strains, including Novarine and Jelly Cocktail, are now available, aiming to attract both medical patients and adult-use customers. Grassroots products utilize high-quality genetics for a superior experience and are now offered at all Curaleaf locations in New Jersey. CEO Matt Darin emphasizes the brand's commitment to quality as it seeks to resonate with New Jersey's cannabis community.

Curaleaf Holdings announced the opening of its new Palm Beach Gardens dispensary and the launch of BlueKudu chocolate products in Florida. The dispensary, located at 3540 Northlake Blvd., will open on January 13, expanding Curaleaf's retail footprint to 56 locations in the state and 146 nationwide. The new BlueKudu flavors, espresso dark chocolate and caramel milk chocolate, will also be available for preorder. A grand opening celebration is set for January 20, featuring giveaways and local vendors.